my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Takeda Pharmaceutical Company Limited announced it has completed its acquisition of Nycomed A/S for 9.6 billion Euro on a cash-free, debt-free basis and made Nycomed a wholly owned subsidiary of Takeda effective the same day. Dr. Frank Morich has been named CEO of Nycomed in addition to his current more
Takeda Pharmaceutical Company Limited announced that TAK-438 has entered into Phase III clinical trials in Japan for the treatment of patients with acid-related diseases such as reflux esophagitis.TAK-438, originated by Takeda, is a potassium-competitive acid blocker (P-CAB) that suppresses gastric more
Takeda Pharmaceutical Company Limited announced that it has received an official notice from the Pharmaceutical Development Support Center with regard to the granting of a government subsidy for which it had applied. Takeda was notified in writing on July 6 of this decision, and the company has now more
Introduction GlobalData, the industry analysis specialist, has released its new report, “Type 2 Diabetes - Global Drug Forecasts and Treatment Analysis to 2020”. The report is an essential source of information and analysis on the global type 2 diabetes therapeutics market. The report provides comp more
Introduction GlobalData, the industry analysis specialist, has released its new report, “Osteopenia Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Osteopenia Therapeutics market. The report identifies the more
TechNavio’s analysts forecast the Rheumatoid Arthritis market in Japan to grow at a CAGR of 29.2 percent over the period 2011–2015. One of the key factors contributing to this market growth is the high prevalence rate of patients suffering from rheumatoid arthritis. The Rheumatoid Arthritis Drugs ma more
Home About us Pronova BioPharma in brief Production facilities History Our business concept Vision, values and strategy Ethical guidlines Health, safety and environment Human resources Management team Board of directors Product Omacor/Lovaza Production process Market Distribution and partners Resear more
glossary media library contact us close Latest News Novartis Exercises its Right to Purchase Additional Shares of Alnylam Common Stock Alnylam Completes Key Technology Transfer Objectives in its Takeda Alliance and Earns $20 Million Payment Our Ventures Regulus Therapeutics Inc. is a more
| | Home | Sitemap | Contact Us Search Ranbaxy for Quick Links Select Link About us Board of Directors Executive Team Corporate Social Responsibility Business Development Annual Report 2007 Corporate Presentation Media Contacts Select a Country Australia Austria Baltics Belg more
Watchlist
This is where you can add this topic to your personal favourites
About CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2012 CHEMIE.DE Information Service GmbH, All rights reserved
